Swainsonine

Key Product Details

Product Description

Swainsonine is an inhibitor of α-mannosidase II which inhibits glycoprotein processing. Displays anticancer and immune modulatory properties.

Product Specifications for Swainsonine

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Swainsonine

The following data is based on the product molecular weight 173.21.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

4 3 2 1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.5 mM	11.55 mL	57.73 mL	115.47 mL
2.5 mM	2.31 mL	11.55 mL	23.09 mL
5 mM	1.15 mL	5.77 mL	11.55 mL
25 mM	0.23 mL	1.15 mL	2.31 mL

Calculators

Background References

References are publications that support the biological activity of the product. See our Citations tab to view 11 publications citing the usage of this product.

• Olden The potential importance of swainsonine in therapy for cancers and immunology. Pharmacol.Ther. 1991 PMID: 1754603
• Sun Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine. Phytomedicine 2007 PMID: 17097281
• Tulsiani Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of golgi mannosidase II. J.Biol.Chem. 1982 PMID: 6806288

Product Documents for Swainsonine